abagovomab 35
abciximab 37
abituzumab 24
abrilumab 24
actoxumab 20
adalimumab 21
aducanumab 16
afasevikumab 18
alacizumab_pegol 14
alemtuzumab 35
alirocumab 25
amatuximab 47
andecaliximab 29
anifrolumab 23
anrukinzumab 20
aprutumab 19
aprutumab_ixadotin 19
arcitumomab 25
ascrinvacumab 8
atezolizumab 16
atinumab 18
avelumab 17
basiliximab 32
bavituximab 43
begelomab 29
benralizumab 33
bevacizumab_beta 24
bezlotoxumab 20
bimagrumab 23
bleselumab 24
blinatumomab 36
blosozumab 31
bococizumab 22
brazikumab 19
brentuximab_vedotin 37
briakinumab 20
brodalumab 17
brolucizumab 28
brontictuzumab 30
burosumab 24
cabiralizumab 31
camrelizumab 16
canakinumab 24
cantuzumab_ravtansin 51
carlumab 18
carotuximab 29
cergutuzumab_amunaleukin2 31
cergutuzumab_amunaleukin 31
certolizumab_pegol 27
cetiximab 50
citatuzumab_bogatox 30
cixutumumab 32
clivatuzumab_tetraxetan 28
codrituzumab 33
conatumumab 17
concizumab 30
crenezumab 23
crizanlizumab 28
crotedumab 24
dacetuzumab 26
daclizumab 21
dalotuzumab 37
dapirolizumab_pegol 29
daratumumab 16
dectrekumab 12
demcizumab 29
denosumab 11
depatuxizumab 29
depatuxizumab_mafodotin 29
dezamizumab 26
dinutuximab 43
diridavumab 27
domagrozumab 18
drozitumab 24
duligotuzumab 21
durvalumab 16
dusigitumab 23
efalizumab 38
efungumab 32
eldelumab 20
elezanumab 27
elgemtumab 15
elotuzumab 21
emactuzumab 23
emapalumab 31
emibetuzumab 20
enavatuzumab 27
enfortumab_vedotin 15
enoblituzumab 22
enokizumab 26
enoticumab 23
ensituximab 43
eptinezumab 21
erenumab 25
etaracizumab 15
etrolizumab 24
evinacumab 25
evolocumab 23
farletuzumab 8
fasinumab 27
fezakinumab 27
fibatuzumab 14
ficlatuzumab 26
firivumab 38
flanvotumab 26
fletikumab 31
foralumab 17
foravirumab 18
fremanezumab 30
fresolimumab 20
fulranumab 22
futuximab 32
galcanezumab 22
ganitumab 32
gantenerumab 16
gemetuzumab 35
gemtuzumab2 30
gemtuzumab 28
gevokizumab 27
girentuximab 31
glembatumumab 21
glembatumumab_vedotin 21
guselkumab 25
ibalizumab 30
ibritumomab 43
icrucumab 15
idarucizumab 37
ifabotuzumab 14
imalumab 19
imgatuzumab 25
inclacumab 24
indatuximab_ravtansin 38
indusatumab 21
inebilizumab 25
intetumumab 17
iodine_girentuximab 32
ipilimumab 11
iratumumab 18
isatuximab 39
itolizumab 28
ixekizumab 34
labetuzumab_govitecan 27
lambrolizumab 31
lampalizumab 28
lanadelumab 19
landogrozumab 19
laprituximab 33
lebrikizumab 41
lendalizumab 27
lenzilumab 22
lifastuzumab_vedotin 27
ligelizumab 23
lilotomab 43
lirilumab 29
lodelcizumab 21
lokivetmab 25
lorvotuzumab_mertansin 28
lucatumumab 32
lumretuzumab 22
lupartumab 19
lutikizumab 21
margetuximab 38
milatuzumab 42
mirvetuximab 39
mirvetuximab_soravtansin 39
modotuximab 44
mogamulizumab 32
monalizumab 24
motavizumab 40
moxetumomab_pasudotox 34
namilumab 27
naratuximab 35
naratuximab_emtansin 35
narnatumab 20
navicixizumab2 29
navicixizumab 30
navivumab 35
necitumumab 14
nemolizumab 31
nesvacumab 20
nivolumab 15
obiltoxaximab 25
obinutuzumab 37
ocaratuzumab 29
ofatumumab 22
olaratumab 23
olokizumab 26
omalizumab 22
onartuzumab 25
ontuxizumab 37
opicinumab 17
orticumab 17
otelixizumab 40
oxelumab 14
ozanezumab 36
pamrevlumab 14
panobacumab 32
parsatuzumab 31
pasotuxizumab 23
pateclizumab 22
patritumab 28
pembrolizumab 31
perakizumab 25
pidilizumab 25
pinatuzumab_vedotin 19
plozalizumab 34
pogalizumab 28
polatuzumab_vedotin 22
ponezumab 41
prezalumab 18
pritoxaximab 45
quilizumab 21
racotumomab 33
radretumab 18
ralpancizumab 24
ramucirumab 16
ranevetmab 34
ranibizumab 27
refanezumab 26
remtolumab 21
rilotumumab 18
rinucumab 22
risankizumab 35
rituximab 26
rivabazumab 24
robatumumab 20
roledumab 36
romosozumab 28
rontalizumab 27
rosmantuzumab 25
rozanolixizumab 24
sacituzumab 32
sacituzumab_govitecan 32
samalizumab 29
sapelizumab 24
sarilumab 19
secukinumab 18
seribantumab 18
setoxaximab 50
sifalimumab 16
siltuximab 31
simtuzumab 32
sirukumab 14
solanezumab 29
solitomab 33
stamulumab 25
suptavumab 26
suvizumab 21
tabalumab 22
tadocizumab 22
tamtuvetmab 38
tanezumab 24
tarextumab 14
tavolixizumab 23
telisotuzumab 33
teplizumab 25
tesidolumab 32
tezepelumab 31
tigatuzumab 19
tildrakizumab 24
timolumab 20
tisotumab 16
tosatoxumab 43
tositumomab 40
tralokinumab 35
trastuzumab 24
tregalizumab 24
trevogrumab 14
ublituximab 33
urelumab 24
ustekinumab 31
utomilumab 28
vadastuximab 31
vadastuximab_talirin 31
vandortuzumab_vedotin 24
vantictumab 23
vanucizumab2 24
vanucizumab 36
varlilumab 19
vatelizumab 25
vedolizumab 31
veltuzumab 19
vesencumab 13
vorsetuzumab 22
vorsetuzumab_mafodotin 22
vunakizumab 37
xentuzumab 22
zatuximab 44
